Last reviewed · How we verify
NCT06597604: TENATAC
Evaluation of the Effectiveness and Security of TenaTac® in the Prevention of Air Leaks in Thoracic Surgery
NA trial testing Intraoperative use of TenaTac in lung surgery in Lung Surgery in 154 participants. Not yet recruiting.
31 December 2025
Quick facts
| Lead sponsor | Hopitaux Prives de Metz, Groupe UNEOS |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 154 |
| Start date | 1 March 2025 |
| Primary completion | 31 December 2025 |
| Estimated completion | 30 June 2026 |
| Sites | 2 locations across France |
Drugs / interventions tested
- Intraoperative use of TenaTac in lung surgery
- Intraoperative use of usual sealant in lung surgery
Conditions studied
- Lung Surgery — all drugs for Lung Surgery →
Sponsor
Hopitaux Prives de Metz, Groupe UNEOS
Who can join
18 and older, any sex, with Lung Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Lung surgery remains a high-risk procedure, with serious adverse events that can occur later, including postoperative bleeding or hemothorax, pneumopathy or surgical site infection but also ... per- and post-operative air leaks. Majority the air leaks resolve spontaneously within 48 hours but certain cases persist within several days which known as prolonged air leaks, or PAL. Several safe and effective sealing agents are used to contain and or reduce the intensity and incidence of postoperative air leaks, and the time required for drain removal. This protocol assesses the effectiveness of an innovative gelatin-based medical device named TenaTac® (Selentus Science, UK) in preventing air leak after major lung resection.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06597604
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lung Surgery
Currently open trials in the same condition.
- NCT06516198 — Auricular Acupressure in Prehabilitation · NA · recruiting
- NCT06926179 — Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Manageme · recruiting
- NCT06444854 — Patient Reported Outcomes Targeting Early Chest Tube Removal (PROTECTR) Study · NA · recruiting
Other Hopitaux Prives de Metz, Groupe UNEOS trials
Trials by the same sponsor.
- NCT07111104 — Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung Carcinoma · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06597604 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hopitaux Prives de Metz, Groupe UNEOS
- Last refreshed: 3 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06597604.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing